ArticleIEEE transactions on biomedical circuits and systems2024
Integrated Real-Time CMOS Luminescence Sensing and Impedance Spectroscopy in Droplet Microfluidics.
Article in IEEE transactions on biomedical circuits and systems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bioluminescence in Clinical and Point-of-Care Testing.Biosensors · 2025Review
- Integrated Real-Time CMOS Luminescence Sensing and Impedance Spectroscopy in Droplet Microfluidics.IEEE transactions on biomedical circuits and systems · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
High-throughput biosensor screening and optimization are critical for health and environmental monitoring applications to ensure rapid and accurate detection of biological and chemical targets. Traditional biosensor design and optimization methods involve labor-intensive processes, such as manual pipetting of large sample volumes, making them low throughput and inefficient for large-scale library screenings under various environmental and chemical conditions. We address these challenges by introducing a modular droplet microfluidic system embedded with custom CMOS integrated circuits (ICs) for impedance spectroscopy and bioluminescence detection. Fabricated in a 65 nm process, our CMOS ICs enable efficient droplet detection and analysis. We demonstrate successful sensing of luciferase enzyme-substrate reactions in nL-volume droplets. The impedance spectroscopy chip detects 4 nL droplets at 67 mm/s with a 45 pA resolution, while the luminescence detector senses optical signals from 38 nL droplets with a 6.7 nA/count resolution. We show real-time concurrent use of both detection methods within our hybrid platform for cross-validation. This system greatly advances conventional biosensor testing by increasing flexibility, scalability, and cost-efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.